reference/28959981

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/28959981

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	781
issn	1942-0862 1942-0870
issueIdentifier	3
pageRange	773-781
publicationName	mAbs
startingPage	773
bibliographicCitation	Shaw S, Bourne T, Meier C, Carrington B, Gelinas R, Henry A, Popplewell A, Adams R, Baker T, Rapecki S, Marshall D, Moore A, Neale H, Lawson A. Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling. MAbs. 2014 May;6(3):774–82. PMID: 24670876; PMCID: PMC4011921.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_69ca90617b7d37a0646a9e9e0e973023 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0a267447f5d125c2be4e306c830c53c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30012ea806d8207ccf12fda84ac26762 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97e0a852c63fd125602202910fe3eca5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e680f3b7eba42b74ba1eab1162bb41e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd200431a6b2b29e7f22665a5896d718 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_127d2aaaa0cfd85b29a97254bbafcfb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4d2aed32a407f8b2d3de6f5dd337ec62 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97ed9df3d8cd73769024f6229a7813a1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c65fb5d7d8d9b552f15e8307ef64e012 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b68cf45b2f45cc7ebbbf1714077549a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fa3130c2255776f02dd8edecfb4c4e9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05e818b830490ea278d8e7421dfbf426 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b22e7e3b5a0205e6d1964498faa87826
date	2014-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4011921 https://doi.org/10.4161/mabs.28612 https://pubmed.ncbi.nlm.nih.gov/24670876
isPartOf	https://portal.issn.org/resource/ISSN/1942-0870 https://portal.issn.org/resource/ISSN/1942-0862 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36035
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Discovery and characterization of olokizumab: a humanized antibody targeting interleukin-6 and neutralizing gp130-signaling
discusses	http://id.nlm.nih.gov/mesh/M0024272 http://id.nlm.nih.gov/mesh/M0001400 http://id.nlm.nih.gov/mesh/M0182947 http://id.nlm.nih.gov/mesh/M000599009 http://id.nlm.nih.gov/mesh/M0534745 http://id.nlm.nih.gov/mesh/M0011126 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0495929
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_72e7bde785e0ce108136dd1dcb4e41dd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_47dddeb3946ed18c21854d039c9355df

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3569 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID442878635 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID178101695

Total number of triples: 49.